In March 2025, the company announced new strategies for a immediate-to-shopper providing of its Wegovy weight loss drug. The company proven a new pharmacy, called NovoCare, which might cost consumers $499 every month for entry to the drug, under 50 percent the price of the drug via other pharmaceutical distribution networks.[fifty three]Problems wi